Cost-effectiveness analysis of neoadjuvant immune checkpoint inhibition (ICI) versus cisplatin-based chemotherapy (CBC) in muscle-invasive bladder cancer (MIBC). Khaki, A., Shan, Y., Nelson, R., Kaul, S., Gore, J. L., Grivas, P., Williams, S. B. LIPPINCOTT WILLIAMS & WILKINS. 2021

View details for DOI 10.1200/JCO.2021.39.6_suppl.419

View details for Web of Science ID 000636801500422